Atossa Therapeutics Inc (ATOS)
1.56
+0.04
(+2.63%)
USD |
NASDAQ |
Apr 26, 09:30
Atossa Therapeutics Total Liabilities (Quarterly): 5.236M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.236M |
September 30, 2023 | 3.444M |
June 30, 2023 | 3.478M |
March 31, 2023 | 2.944M |
December 31, 2022 | 5.568M |
September 30, 2022 | 2.868M |
June 30, 2022 | 3.792M |
March 31, 2022 | 2.322M |
December 31, 2021 | 3.126M |
September 30, 2021 | 1.676M |
June 30, 2021 | 1.796M |
March 31, 2021 | 1.379M |
December 31, 2020 | 15.67M |
September 30, 2020 | 1.567M |
June 30, 2020 | 1.831M |
March 31, 2020 | 0.916M |
December 31, 2019 | 1.334M |
September 30, 2019 | 1.578M |
June 30, 2019 | 1.057M |
March 31, 2019 | 1.528M |
December 31, 2018 | 2.915M |
September 30, 2018 | 3.555M |
June 30, 2018 | 3.011M |
March 31, 2018 | 0.7207M |
December 31, 2017 | 1.225M |
Date | Value |
---|---|
September 30, 2017 | 1.072M |
June 30, 2017 | 1.906M |
March 31, 2017 | 0.7748M |
December 31, 2016 | 1.047M |
September 30, 2016 | 0.8638M |
June 30, 2016 | 0.8743M |
March 31, 2016 | 1.327M |
December 31, 2015 | 2.502M |
September 30, 2015 | 3.298M |
June 30, 2015 | 3.436M |
March 31, 2015 | 3.519M |
December 31, 2014 | 2.266M |
September 30, 2014 | 1.540M |
June 30, 2014 | 1.564M |
March 31, 2014 | 1.082M |
December 31, 2013 | 1.407M |
September 30, 2013 | 1.942M |
June 30, 2013 | 1.774M |
March 31, 2013 | 1.936M |
December 31, 2012 | 1.651M |
September 30, 2012 | 2.291M |
June 30, 2012 | 1.398M |
March 31, 2012 | 0.7793M |
December 31, 2011 | 1.512M |
September 30, 2011 | 1.399M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.916M
Minimum
Mar 2020
15.67M
Maximum
Dec 2020
3.241M
Average
2.322M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
AngioDynamics Inc | 106.14M |
Biolase Inc | 33.14M |
Outset Medical Inc | 190.92M |
Perspective Therapeutics Inc | 22.71M |
Electromed Inc | 6.622M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 96.25M |
Shareholders Equity (Quarterly) | 91.02M |